PMID: 11903506Mar 21, 2002Paper

Sigma receptors: from discovery to highlights of their implications in the cardiovascular system

Fundamental & Clinical Pharmacology
Laurent Monassier, Pascal Bousquet

Abstract

Sigma receptors are the targets of many ligands, of which some (the haloperidol for instance) are psychoactive, and of substances known to have antiarrhythmic effects (amiodarone and clofilium). They are involved in a variety of cardiovascular functions, such as the regulation of cardiac contractility and rhythm and the regulation of coronary and peripheral arterial vasomotricity. This short review will focus on some aspects regarding the ligands, the binding sites, the intracellular coupling and the cardiovascular functions of these enigmatic receptors.

References

Mar 1, 1992·Trends in Pharmacological Sciences·R QuirionD P Taylor
Nov 13, 1990·European Journal of Pharmacology·T Massamiri, S P Duckles
Oct 18, 1988·European Journal of Pharmacology·B L LargentS H Snyder
Sep 7, 1993·European Journal of Pharmacology·A P JeanjeanP M Laduron
Aug 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·Y Ellis, J A Davies
May 12, 1993·European Journal of Pharmacology·K Hashimoto, E D London
Nov 3, 1995·European Journal of Pharmacology·M NovakovaY Eilam
Aug 10, 1996·Lancet·P ClaytonD FitzPatrick
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·M HannerH Glossmann
Dec 13, 1996·Biochemical and Biophysical Research Communications·R KekudaV Ganapathy
Jan 1, 1997·Progress in Neuro-psychopharmacology & Biological Psychiatry·T Maurice, B P Lockhart
Mar 1, 1997·Trends in Pharmacological Sciences·F F MoebiusH Glossmann
May 20, 1997·European Journal of Pharmacology·J K WeatherspoonL L Werling
Jan 13, 1998·Biochemical and Biophysical Research Communications·P SethV Ganapathy
Mar 7, 1998·Journal of Neurochemistry·P SethV Ganapathy
Dec 16, 1998·European Journal of Pharmacology·V H NguyenM J Christie
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·M P Morin-SurunF P Monnet
May 17, 2000·Pharmaceutica acta Helvetiae·L Brasili
May 17, 2000·Pharmaceutica acta Helvetiae·W D Bowen
May 1, 1998·Annals of the New York Academy of Sciences·Yossef Itzhak, Syed F Ali

❮ Previous
Next ❯

Citations

Dec 16, 2011·Amino Acids·Jana Ninković, Sabita Roy
Mar 22, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Shahid Husain, David E Potter
Jun 11, 2004·Annual Review of Biochemistry·Maria WaldhoerJennifer L Whistler
Nov 19, 2010·American Journal of Physiology. Cell Physiology·Molly JohannessenMeyer B Jackson
Mar 13, 2009·American Journal of Physiology. Cell Physiology·Molly JohannessenMeyer B Jackson
May 13, 2009·Comparative Hepatology·Carylyn J MarekMatthew C Wright
Jan 6, 2011·Expert Opinion on Therapeutic Targets·Md Shenuarin Bhuiyan, Kohji Fukunaga
Jun 24, 2004·Expert Opinion on Investigational Drugs·Eric P Zorrilla, George F Koob
Sep 3, 2004·Journal of Clinical Pharmacology·Anne T HarveySheldon H Preskorn
Apr 7, 2005·Fundamental & Clinical Pharmacology·Marcos Adriano Lessa, Eduardo Tibiriçá
Nov 19, 2003·The European Journal of Neuroscience·Francina LangaLluís Montoliu
Apr 11, 2012·Fundamental & Clinical Pharmacology·Annie DelaunoisMichel Guyaux
Jan 31, 2012·Brain Research·Robert R LuedtkeJames W Simpkins
May 26, 2015·European Journal of Pharmacology·John R LeverEmily A Fergason-Cantrell
Jun 10, 2015·Journal of Receptor and Signal Transduction Research·Colin G Rousseaux, Stephanie F Greene
Apr 15, 2004·Bioorganic & Medicinal Chemistry Letters·Richard A GlennonJames B Fisher
Jan 31, 2017·Journal of Enzyme Inhibition and Medicinal Chemistry·Vito BoidoGuglielmina Froldi
Apr 27, 2007·The Journal of Pharmacology and Experimental Therapeutics·Laurent MonassierPascal Bousquet
Sep 26, 2015·Pharmacological Reviews·Esa R KorpiGavin S Dawe
Mar 15, 2005·The Journal of Pharmacology and Experimental Therapeutics·Hongling Zhang, Javier Cuevas
Sep 11, 2020·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Zacharie Saint-GeorgesLauri Tuominen
Feb 24, 2004·CNS Drug Reviews·Deborah L GilmoreRae R Matsumoto
Sep 25, 2020·Journal of Pharmaceutical and Biomedical Analysis·Raluca PopaChristopher R McCurdy
Aug 8, 2021·International Journal of Molecular Sciences·Szabolcs DvorácskóFerenc Bogár

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here